Evaluation of the Safety and Efficacy of K-CAB (Tegoprazan) as Symptomatic Maintenance Therapy in Patients With NERD: A Multicenter, Randomized Double-Blinded Controlled Trial
These findings suggest that alternate-day tegoprazan offers comparable efficacy and safety to daily lansoprazole therapy and may serve as a more flexible and patient-friendly maintenance option for NERD.
Authors
- Ju Yup Lee (ORCID: https://orcid.org/0000-0003-0021-5354)
- Joong Goo Kwon (ORCID: https://orcid.org/0000-0003-3392-785X)
- Kyung Sik Park (ORCID: https://orcid.org/0000-0003-1874-9936)
- Hyeong Ho Jo (ORCID: https://orcid.org/0000-0002-4950-5435)
- Yong Hwan Kwon (ORCID: https://orcid.org/0000-0002-0520-9685)
- Si Hyung Lee (ORCID: https://orcid.org/0000-0001-7221-7506)
- June Hwa Bae (ORCID: https://orcid.org/0000-0003-4117-822X)
- Seong Woo Jeon (ORCID: https://orcid.org/0000-0002-9539-9389)
- Eun Young Kim (ORCID: https://orcid.org/0000-0003-3965-9964)
- Yun Jin Chung (ORCID: https://orcid.org/0000-0002-3622-9216)
- Chang‐Hun Yang (ORCID: https://orcid.org/0000-0003-4036-2981)
Institutions
- Kyungpook National University (KR)
- Daegu Catholic University (KR)
- Yeungnam University College
- Keimyung University (KR)
- Yeungnam University (KR)
Publication Details
- Journal
- The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Published
- 2025-12-05
- DOI
- https://doi.org/10.7704/kjhugr.2025.0054
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00